INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 28 February 2014
Total net assets |
£210.3m |
NAV per share |
381.4p |
Share price |
330.8p |
Total value of unquoted investments |
£26.4m |
Total number of portfolio companies |
95 |
Top Ten Holdings
Company Name |
% NAV |
Biogen |
7.2 |
Gilead |
6.9 |
Regeneron |
5.9 |
Celgene |
5.6 |
Alexion |
4.1 |
Amgen |
3.8 |
Illumina |
3.6 |
Vertex |
3.3 |
Mylan |
3.1 |
Aptiv |
2.3 |
|
----------- |
Total |
45.8 |
Trust Characteristics |
% NAV |
Profitable |
62 |
Turning Profitable 2015 |
9 |
Unprofitable |
29 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
92 |
Europe & UK |
8 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% NAV |
Quoted |
88 |
Unquoted |
12 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 MARCH 2014